Dr Hazrat Bilal’s Post

#MRCPI exam journey Day 10 #Nephroticsyndrome - #Clinical presentation: proteinuria, lipiduria, HTN and peripheral edema. - #For the exam: patient with peripheral #edema , #proteinuria and unilateral #flank pain: #Renal vein thrombosis due to decreased #Antithrombin III.

In patients undergoing PCI, ticagrelor but not clopidogrel monotherapy was non-inferior to DAPT for the prevention of ischemic events and superior for NACE. Major bleeding was similarly reduced with ticagrelor and clopidogrel monotherapy vs DAPT. https://ja.ma/3Tp0HUg

MUST READ in NEJM … IMPORTANT UPDATE from Vaishali Sanchorawala at Boston Medical Center (BMC) … here’s the cliff notes: Consider in differential diagnosis ▶️Nephrotic range proteinuria ▶️Unexplained non ischemic cardiomyopathy ▶️Peripheral neuropathy ▶️Unexplained hepatomegaly ▶️Atypical multiple myeloma 👉🏽nejm.org/doi/full/10.10…

#869 A 81-year-old female who was started on amiodarone 200 mg PO once daily for maintenance of sinus rhythm approximately 9 months ago. She presents to your cardiology clinic for a routine follow-up. Labs are drawn. Which of the following abnormal labs is least likely to be caused from her amiodarone? A. WBC 28 × 109 cells/L B. Aspartate aminotransferase 860 U/L C. Thyroid stimulating hormone 46 mU/L D. Thyroid stimulating hormone 0.004 mU/L Answer =A Amiodarone is a potential source of large amounts of inorganic iodine,so it can cause hypothyroidism or hyperthyroidism. Also ,liver enzyme elevations and/or hepatotoxicity are also associated with amiodarone use and should be monitored closely. The incidence of leukocytosis due to amiodarone is unlikely. #cardilogy #cardiac_drug #arrhythmia

Propensity score-matched study (DOI: 10.1016/j.ejso.2024.108339) of 62 patients with Bismuth II hilar cholangiocarcinoma reports minor hepatectomy results in shorter operation times, reduced blood loss, and faster bowel recovery compared to major hepatectomy. Both procedures had similar postoperative outcomes, quality of life, and survival rates. While promising, the results call for verification through larger, more extensive trials. #CancerSurgery #ClinicalDecisionMaking #PatientRecovery #MedicalResearch

This study explores the efficacy of a novel ECMELLA setup combining veno-arterial extracorporeal membrane oxygenation (va-ECMO) with a micro-axial flow pump in treating cardiogenic shock (CS). Analyzing data from 67 patients treated between December 2020 and December 2022, the study found the technique feasible and effective, with a 27% myocardial recovery rate and a 24% transition rate to #CardiogenicShock #ECLS #ECMELLA #Impella #VAECMO

Ophthopedia Update:The consistency of Anti-Toxocara IgG between the Aqueous Humor and Vitreous of Patients with Clinically Suspected Ocular Toxocariasis: To assess the consistencies of anti-Toxocara IgG (T-IgG) and Goldmann-Witmer coefficient (GWC) between paired aqueous humor (AH) and vitreous samples from patients with clinically-suspected ocular toxocariasis (OT). #Ophthalmology #Ophthotwitter #Scicomm

Consistent with our previouslypublished meta analyses : This meta-analysis showed a significant improvement in overall survival after primary tumour resection (PTR) compared with no PTR (hazard ratio [HR], 0.60; 95% confidence interval [CI], 0.53–0.67; p < 0.00001). Similar results were seen in patients with 1 metastatic organ, ≤2 metastatic organs, and ≤3 metastatic organs. Oligometastatic patients are expected to be a beneficial subgroup for PTR in patients with MBC, especially when metastasis occurs in only one organ. https://lnkd.in/dPbDu-pK

Cirrhosis crash course video # 24 𝗛𝗲𝗽𝗮𝘁𝗼𝗿𝗲𝗻𝗮𝗹 𝘀𝘆𝗻𝗱𝗿𝗼𝗺𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗪𝗵𝗮𝘁 𝗶𝘀 𝘁𝗵𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗽𝗮𝘁𝗵𝗼𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝘆? Renal injury pattern is pre-renal 𝗪𝗵𝗮𝘁 𝗶𝘀 𝘁𝗵𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗴𝗼𝗮𝗹? 1. Volume expansion 2. Increase renal perfusion 𝗛𝗼𝘄 𝗱𝗼 𝘄𝗲 𝗱𝗼 𝗶𝘁? 1. Stop diuretics 2. Expand intravascular volume with albumin 3. Increase BP by giving pressors (terlipressin, midodrine, norepinephrine, octreotide) 4. Dialysis as a bridge to liver transplantation Please like, follow, and share this content Wanna help me the most -> please 𝗿𝗲𝗽𝗼𝘀𝘁 Wanna see all my future posts? Hit the 𝗯𝗲𝗹𝗹 icon next to my profile Wanna see all my videos 𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲 here --> https://lnkd.in/gGg7KuBt

This study explores the efficacy of a novel ECMELLA setup combining veno-arterial extracorporeal membrane oxygenation (va-ECMO) with a micro-axial flow pump in treating cardiogenic shock (CS). Analyzing data from 67 patients treated between December 2020 and December 2022, the study found the technique feasible and effective, with a 27% myocardial recovery rate and a 24% transition rate to #CardiogenicShock #ECLS #ECMELLA #Impella #VAECMO